Article
Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma.
Hepatology (Baltimore, Md.) - 1 Apr 2013
Mizukoshi Eishiro, Yamashita Tatsuya, Arai Kuniaki, Sunagozaka Hajime, Ueda Teruyuki, Arihara Fumitaka, Kagaya Takashi, Yamashita Taro, Fushimi Kazumi, Kaneko Shuichi
Abstract excerpt
UNLABELLED: Radiofrequency ablation (RFA) is one of the treatments for hepatocellular carcinoma (HCC) and is known to enhance host immune response. However, the epitopes to which enhanced immune responses occur, the impact on patient prognosis, and the functions and phenotype of T cells induced are still unclear. To address these issues, we analyzed immune responses before and after RFA in 69 HCC patients using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.